Lv4
580 积分 2023-08-10 加入
Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface
7天前
已完结
Targeting EGFR in Pancreatic Cancer Treatment
14天前
已完结
Legumain-Cleavable Top1i Antibody-Drug Conjugates without Self-Immolative Spacers Demonstrate Potent Antitumor Activity
16天前
已完结
Discovery and In Vivo Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity
1个月前
已完结
A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies
1个月前
已完结
A novel FAP-targeting antibody-exatecan conjugate improves immune checkpoint blockade by reversing immunosuppressive microenvironment in pancreatic cancer
1个月前
已完结
KRAS degradation averts PDAC chemoresistance
1个月前
已完结
Top advances of the year: Small cell lung cancer
2个月前
已完结
A patent review of PRMT5 inhibitors to treat cancer (2018 - present)
2个月前
已完结
SAM Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance
2个月前
已完结
皖公网安备34019202002308
